$3,299.00
In Stock
Expovio (Xpovio) – antitumor agent – exportin 1 inhibitor (XPO1)
Nexpovio (selinexor) represents an important milestone in the targeted treatment of multiple myeloma for people who have undergone at least four previous therapies. This prescription drug offers hope to patients suffering from relapsed or refractory multiple myeloma.
The pharmacological mechanism of action of Expovio targets the protein MDM2, which plays an important role in the survival of cancer cells. By affecting this protein, the drug prevents malignant cells from thriving, opening the way to a new therapeutic approach.
Active ingredient: selinexor
Prescription medicine
Nexpovio 20 mg is delivered from Germany
